Janssen Biotech, Inc. drugs

18 results

  • darzalex - daratumumab injection, solution, concentrate

    (Daratumumab)
    Janssen Biotech, Inc.
    DARZALEX treats multiple myeloma in adults — used in newly diagnosed patients ineligible or eligible for stem cell transplant, and in relapsed/refractory cases after one or more prior therapies, as part of various combination regimens or as monotherapy.
    Medication Details
    Drug Interactions

  • darzalex faspro - daratumumab and hyaluronidase - fihj

    (Daratumumab And Hyaluronidase-Fihj (Human Recombinant))
    Janssen Biotech, Inc.
    DARZALEX FASPRO treats adult patients with multiple myeloma (newly diagnosed or relapsed/refractory, across various combination regimens), high-risk smoldering multiple myeloma, and newly diagnosed light chain (AL) amyloidosis. Not recommended for AL amyloidosis with NYHA Class IIIB/IV cardiac disease outside clinical trials.
    Medication Details
    Drug Interactions

  • remicade - infliximab injection, powder, lyophilized, for solution

    (Infliximab)
    Janssen Biotech, Inc.
    Remicade is a TNF blocker for adults and children 6+ with moderate-to-severe Crohn's disease or ulcerative colitis unresponsive to conventional therapy. Also indicated for rheumatoid arthritis (with methotrexate), ankylosing spondylitis, psoriatic arthritis, and chronic severe plaque psoriasis in adults.
    Medication Details
    Drug Interactions

  • rybrevant - amivantamab injection

    (Amivantamab)
    Janssen Biotech, Inc.
    Rybrevant treats adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 19 deletions, exon 21 L858R substitutions, or exon 20 insertion mutations. Used first-line (with lazertinib or carboplatin/pemetrexed) or after prior treatment progression.
    Medication Details
    Drug Interactions